Preliminary in Vitro- Investigation on Antimicrobial Activity of Mononuclear and Dinuclear Iron (III) Complexes by Balasubramanian, S. Sujatha *, K.
 
 
 
Journal of Experimental Sciences Vol. 2, Issue 5, Pages 07-12 [2011] 
www.jexpsciences.com 
 
Regular Article 
 
Preliminary in Vitro- Investigation on Antimicrobial Activity of 
Mononuclear and Dinuclear Iron (III) Complexes 
 
S. Sujatha *, K. Balasubramanian 
 
Post Graduate and Research, Department of Chemistry, National College, Trichirapalli-620 011, India 
 
ABSTRACT: In vitro effect of two dinuclear and mononuclear iron 
complexes with different ligands was examined on Gram positive 
and Gram negative bacterial strains. Broad spectrum antibiotic 
oxytetracycline was used as control. The experiment was performed 
by the routine agar-diffusion method of bauer et al. and the method 
of  minimum  inhibitory concentrations (MICs). It was  found  that 
mononuclear complexes expressed antibacterial effect in vitro, 
especially against Gram (+) strains. The minimum inhibitory effect of 
Fe (NADP) Cl2 was more pronounced. 
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Introduction 
Now days, more and more strains of pathogenic microorganisms, 
including staphylococci, streptococci and enterobacteria, become 
resistant to many of available antibiotics and chemotherapeutic 
agents1-4. There are three main types of non-haem iron intradiol- 
cleavage enzyme catechol 1, 2-dioxygenases, protocatechuate 3, 4- 
dioxygenasesand chlorocatechol 1, 2 -dioxygenases. Catechol 1, 2- 
dioxygenases are, with one or two possible exceptions5-6    Dimers of 
either identical or non-identical subunits7  with molecular mass of 
30.5±34 k Da8-9.Catechol 1, 2-dioxygenases also perform extradiol 
cleavage of meta-substituted substrates such as 3-methylcatechol or 
3-methoxycatechol10-11. Chlorocatechol1, 2-dioxygenases, by 
contrast, do not generally perform significant extradiol cleavage of 
aromatic substrates12. Murakami et al.] ¹³ that there is a subfamily of 
catechol 1, 2-dioxygenases in Gram positive bacteria that is clearly 
distinct from the two subfamilies of catechol and chlorocatechol 1, 
2-dioxygenases in Gram-negative bacteria. The present work is an 
extension to such studies and deal with the synthesis and biological 
evaluation (antibacterial and antifungal activity) of Fe(III) complexes 
of some Schiff’s base derived from different aromatic 
/heteroaromatic carboxyaldehydes and 4,4’ substituted 
heteroaromatic ammines. In order to get an insight into the role, the 
behavior of Schiff’s   bases have gained a great deal of attraction. 
The azomethine linkage of (N=CH) is a significant feature that make 
Schiff’s base  ligands  the  interesting  candidates  for  biological 
activities  as  well as  co-ordination /  chelation  with  metal  ions14- 
16.There are data published about the antibacterial effect of iron and 
different iron compounds. (Diarra et al., 1996¹⁷ Gvozdyak et al., 
199618 Bacchi et al.,199919 Donde et al., 200320) 
 
 
Material and Methods: 
The experiment were performed with two complexes of mono and 
di-iron derivative  with ligands containing catechol derivatives and 2- 
hydroxy naphthaldehyde Moieties like Schiff’s  base 1 and2) ;N,N bis 
(naphthy2-hydroxy)1,3diamminopropane(NHDAP);N,Nbis(naphthy- 
hydroxy) triethylenetetramine (NHTEN). 3&4, N,Nbis(t- 
butylsalicylichydroxy 4,4”diamminodiphenylmethane)(TBSHDM); 
N,N-bis (t-butylsalicylichydroxy) 4,4” oxydianiline – (TBSHOD). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1(ligand 1 esi-ms details) 
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Synthesis of ligand L3: 
1, 3- bis [3’-aza-4’-(5”-naphthyl 2”-hydroxyphenyl -1-ol]-propane 1, 
3diamine 
A substance of 1,3 diamino 2-hydroxy propane (0.09012g (1mmol) 
was  added in 100  ml of  dichloromethane to the solution of  2- 
hydroxy naphthaldehyde 0.344g (2mmol) at room temperature. The 
white solution stirred for 30 minutes. A yellow product was isolated. 
The  product  was  collected  by  filtration,  washed  with  minimum 
volume of dichloromethane and dried in vacuo P 4O 10  (89%) . 
Mp<150 C25H 22O 3N2 (398.4589) 
1H NMR (CDCl3): δ (phenolicOH) 14.4(s,2H); (Aromatic hydrogen) 
9.21-6.93(8H); (Allylic  OH)  4.84(s, 1H);  3.73 (t,4H); 2.76(s,1H); 
2.66(s,2H) 
 
 
 
 
 
Experimental Section 
Synthesis of ligand L1: 
{N, N diphenyl methyl bis(3,5-di-tert-butylsalicylideneimine)},(L1) 
3, 5di-t-butyl-2-hydroxybenzaldehyde (0.468, 2. 0mmmol) in ethanol 
Synthesis of ligand L4: 
Synthesis of (1,3 bis –[3’-aza-4’-(5”-napthyl-2”-hydroxypheny)-
prop- 
4-en-1-yl)]-ethane 1,2-diamine(H2L) 
A solution of Triethylenetetramine (0.1462g (1mmol) was added in 
100 ml of dichloromethane to the solution of 2-hydroxy 
naphthaldehytde 0.344g  2mmol)  at  room  temperature.  The  red 
colour solution stirred for 30 minutes. A yellow product was isolated. 
The  product  was  collected  by  filtration  washed  with  minimum 
(100ml) was mixed with 4, 4 diamminodiphenylmethane (0.198, 1. 
0mmmol) and stirred for 30mins.The mixture was stirred and gently 
refluxed  at  room  temperature  for  8  hours.  The  ethanol  was 
volume of dichloromethane and dried in vacuum P4 O10 
30O2 N4 (454.5) 
Mp<150 C2 8 H 
evaporated  under  rotavapor  and  the  resulting  yellow  solid  was 
recrystallised with dichloromethane. Yield: 80% 
Mp<180°C C43H54O2N 2 (630.9) 
1H  NMR  (CDCl3):  δ  (phenolic  OH)  13.636(s,  2H)  ;):  δ  8.38- 
8.36(CH=N)   δ(Aromatic)   7.2(d,2H);7.4(d,2H);   δ   7.4-7.2(m,8H) 
;4.02(S,2H); δ 1.29 -1.34 (S,18H) (t-butyl) 
 
Preparation of the complex Fe2 (L1)2: 
To a 20 ml of DMF solution of the ligand (0.136g,1.0mmol), 
triethylammine (0.2g, 280µml, 2.0mmol) was added to abstract the 
phenolic   hydrogen   of   the   ligand   added   solution   of   Ferric 
chloride(0.0324,1.0mmol)  dissolved  in  DMF  (20ml).The  resulting 
dark  greenish solution  was  refluxed  for  4  hours  and whereby,it 
changed  red solid. Red precipitate was obtained on evaporation of 
the solution at room temperature for several days. The complex was 
recrystallised from Petroleum ether. 
Mp<180°C C86H104O4 N4 Cl2.Fe2.(2H20)-(1494.9) 
 
Synthesis of the ligand L2: 
Synthesis of [N, N -4”-phenoxy–bis(3,5-di-tert- 
butylsalicylideneimine)] – benzene 
3,  5  di  t-  butyl-2-hydroxybenzaldehyde (0.468,  2.  0mmmol)  in 
ethanol (100ml) was mixed with 4, 4 oxydianiline (0.2g 1.0mmmol) 
and stirred for 30mins. The mixture was stirred and gently refluxed 
at room temperature for 8 hours. The ethanol was evaporated under 
rotavapor and the resulting shining dark yellow flakes was 
recrystallised with dichloromethane. 
Yield: 80% 
Mp<180°C C42 H52 O3 N2 (632.89) 
1H NMR (CDCl3): δ (phenolic OH) 13.6(s, 2H); δ 8.36-8.39(CH=N) δ 
(AROMATIC) 7.18(d, 2H) ;6.68 (d,2H); δ 6.9-7.2(m,8H) ; δ 1.29 - 
1.34(S, 18H) (t-butyl) 
 
Preparation of the complexesFe2 (L2)2: 
To a 20 ml of the DMF solution ligand(0.131g,1.0mmol), 
triethylammine (0.2g, 280µml, 2.0mmol)  was added to abstract the 
phenolic hydrogen of the ligand, followed by a solution of Ferric 
chloride(0.034g.1.0mmol) dissolved  in  DMF  (20ml).The  resulting 
dark greenish solution was refluxed for 4 hours and   whereby, it 
changes to red solid. Red precipitate was obtained on evaporation of 
the solution at room temperature for several days. The complex was 
recrystallised from Petroleum ether. 
Mp<180° C84 H100O6N4 Cl2.Fe2.(2H20)-1498.9 
1H NMR (CDCl3): δ (phenolicOH) 14.4(s,2H); (Aromatic hydrogen) 
8.71-7.19(8H); (Allylic OH) 3.64(t, 4H); 2.74 (t,4H); 2.75(t,4 H); 
2.16(s,2H) 
 
Preparation of complexes (III&IV) 
The complexes were synthesized by addition of FeCl3.5H20 
(0.0324g/1mmol) in  20mL of  DMF  to  a  solution  of  Schiff  base 
(1mmol ligand in 20 ml DMF) in the presence of Et3NH (0.2ml, 
2mmol) and the reaction mixture was heated under   reflux  for 2 
hrs. The volume of the obtained solution was reduced to one-half by 
evaporation. The obtained red solid powdered material of both 
complexes (III &IV) were f iltered washed with absolute acetonitrile 
and placed in the desiccator for two days. 
 
Screening of antimicrobial activity 
Test microorganisms 
Klebsiella pneumoniae, Salmonella typhi 
Preparation of discs 
Known quantity of extracts or fractions was dissolved in DMSO: 
methanol of 1:1 ratio. This in turn was diluted with equal volume of 
Phosphate Buffered Saline (PBS pH7).It was then filter sterilized by 
making use of sortorious syringe f ilter of pore size 0.22µm. sterile 
discs  of  6mm  diameter  (Himedia)  were  loaded  with  various 
concentration of extract and fractions and were dried. Dried discs 
were stored in sterile containers till use. Solvent loaded discs were 
also prepared and used as negative control. Oxytetracyline loaded 
Hi-Media discs were used as positive control. 
 
Preparation of inoculum 
Clinical isolates and referral strains were inoculated in nutrient broth 
and incubated at37°C for 4 hours in a shaker (Orbitech, Scigenics, 
India) and were used for anti-bacterial test and to look for the MIC 
ofvarious extracts and fractions. 
 
Determination of Antibacterial activity 
Disc  Diffusion  method  was  followed  (Bauer  et  al.  1996)²¹  to 
determine the antibacterial activity of various extracts and fractions. 
Petriplates containing 20ml of Mueller Hinton agar were seeded with 
4 hours old fresh culture of clinical isolates and referral strains. By 
making use of template drawn extracts and fractions loaded discs 
were  dispensed on  the  solidif ied  Mueller  Hinton  agar  with  test 
organisms. Oxytetracyline antibiotic disc obtained from M/s Hi-Media 
Laboratories Ltd, Mumbai was used as a positive control and solvent 
loaded discs were used as  negative control. This was incubated at 
37°C  for  24  hours  in  an  incubator  (Rands  SBC).The  test  was 
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performed intriplicates. The zone of  inhibition was  measured by 
making use of Antibiotic Zone scale (Hi –media) 
 
Determination of Minimum Inhibitory Concentration 
NCCLS for disc diffusion method and agar dilution technique for MIC 
testing. Stock solution of  various plant extract was  prepared by 
making use of DMSO: methanol in the ratio of 1:1 which in turn was 
diluted  with  equal  volume  of  phosphate buffered  saline,  pH  7. 
Mueller  Hinton agar  was  prepared, sterilized  and  kept  ready  in 
molten condition. 20ml of the molten media was taken and was 
mixed with known concentration of different extracts/fractions and 
were added in different tubes. This mixture was swirled carefully for 
complete mixing of extract and media and poured on to the plate. 
After getting solidif ied it was inoculated with the test organism and 
standard organism. The plates were incubated at 37°C for 24 
hours. MIC was recorded on the growth of the organisms. 
 
Results and Discussions 
The results obtained from the study are presented in Table 1 and 
Table  2.  The  compound  Fe(NHAD)Cl2   at  the  dose  of  100µg/ml 
showed 75% antibacterial activity against the Gram positive bacteria 
S. pyogens, 100% against Micrococcus luteus, Lactobacillus sp and 
Bacillus subtilis (13-22mm inhibitory zones) but only 50% against 
the five Gram negative organisms used in this study (13-16mm 
inhibitory zones). Fe (NHTEN)Cl2 at the dose of 100µg/ml was 
effective against two Gram positive (ie)  Lactobacillus sp and S. 
aureus) (14-21mm inhibitory zones) and three Gram negative 
bacteria(13-15mm inhibitory  zones).  Fe2   (TBSHOD)Cl2      with  the 
same dose of 100µg/ml exhibited antibacterial activity against all 
Gram–positive bacteria (12-22mm inhibitory zones) and four Gram– 
negative bacteria (12-14mm inhibitory zones). Fe2(TBSMD)Cl2  with 
similar dose as earlier mentioned  showed a pronounced effect on all 
Gram positive bacteria(9-20mm inhibitory zones) and four Gram 
negative bacteria( 10-14mm inhibitory zones). Most of the bacterial 
strains used as test system in our investigations showed high 
susceptibility to the broad spectrum antibiotic oxytetracyline. 
Mononuclear and Binuclear ligands and complexes were synthesized 
and subjected to antibacterial susceptibility test against both Gram 
positive and Gram negative pathogens using disc diffusion and drug 
dilution method. L1 and L2 were the dinuclear ligands, L3 and L4 
were the mononuclear ligands similarly C1 and C2 were dinuclear 
complexes and C3 and C4 were mononuclear complexes. 
Antimicrobial activities of four different ligands revealed that more 
significant activity was  exhibited by L3  against Lactobacillus sp. 
(18mm) (Table 1) followed by L4 against Aeromonas sp., (16mm). 
The pathogens like Shigella dysenteriae (10mm by L4 &  L3and 
11mm each by L1 & L2), Bacillus subtilis (13mm by L2 & L3 and 
12mm each by L4 & L1); Pseudomonas aeruginosa (12mm each by 
L1, L3, L4& L2); Streptococcus pyogenes (12mm  by L3; 13mm by 
L2; 11 mm by L4 & 9mm by L1); Klebsiella pneumoniae (13mm by 
L1, 11mm L3 and 7mm by L4 &12mm by L2); Streptococcus faecalis 
(12mm by L1; 10mm by L3 and 9mm by L4 & 11mm by L2) were 
effectively inhibited by all the ligands tested at 100 µ g/disc 
concentrations. When these ligands were complexed with Fe ions 
showed better inhibitory effect against all the pathogens tested at 
100µ g/disc concentrations (Table 1). C3 has been considered as the 
ideal  complex,  which  showed  better  activity  against  all  the 
pathogens tested at 100 µg/disc concentrations. Zone of inhibition 
produced by the C3 complex ranges from10mm to 22mm. Though 
other complexes produced higher zone of inhibition against any one 
of the organism (C1 produced 20mm against Aeromonas sp., C3 
produced 22mm against Lactobacilli sp., and C4 produced 21mm 
against  Lactobacilli sp.,),  they  didn’t  exhibited  inhibitory activity 
against important gram positive and gram-negative pathogens (C1- 
Micrococcus luteus; C3-Enterobacter aerogenes and C4 – Salmonella 
paratyphi). 
 
 
Table 1: Inhibitory effect of pathogenic bacteria in the agar-diffusion method for ligands&Complxesin mm at 100µg/ml 
 
Microrganisms L1 L2 L3 L4 C1 C2 C3 C4
Escherichia coli 9 10 12 11 14 12 16 13 
Salmonella Typhi 11 0 9 10 12 11 13 12 
Shigella Dysenteriae 11 11 10 10 14 17 14 12 
Pseudomonas aeruginosa 12 12 12 12 11 15 13 16 
Aeromonas sp 10 11 12 16 20 16 12 10 
Lactobacillus sp. 15 13 18 9 12 20 22 21 
Staphylococcus aureus 9 11 11 10 13 13 12 14 
Bacillus subtilis 12 13 13 12 12 14 16 15 
Streptococcus pyogens 9 13 12 11 14 13 14 10 
Enterobacter aerogens 10 12 0 10 10 14 20 15 
Klebsiella pneumoniae 13 12 11 7 14 14 15 10 
Micrococcus luteus 7 0 13 0 0 13 17 10 
Salmonella paratyphi 0 12 9 0 12 10 13 0 
Streptococcus facecalis 12 11 10 9 12 13 15 12 
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Figure:2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Minimum Inhibitory effect of pathogenic bacteria in the agar-diffusion method for ligands and 
Complexes 
 
Microrganisms L1 L2 L3 L4 C1 C2 C3 C4 
Escherichia coli 100 100 100 100 50 50 25 50 
Salmonella Typhi 125 150 125 125 75 150 50 50 
Shigella Dysenteriae 150 --- 150 150 150 -- 125 175 
Pseudomonas aeruginosa 200 125 200 200 200 50 100 50 
Aeromonas sp 125 125 --- --- 50 100 25 200 
Lactobacillus sp. 100 200 125 125 75 75 50 50 
Staphylococcus aureus 150 200 175 175 100 200 75 50 
Bacillus subitilis 150 150 200 200 125 200 100 100 
Streptococcus pyogens 200 200 200 200 75 125 50 200 
Enterobacter aerogens 250 200 100 100 200 125 25 50 
Klebsiella pneumoniae 175 125 200 200 75 125 50 200 
Micrococcus luteus --- ---- 125 200 --- ---- 50 200 
Salmonella paratyphi 200 125 -- -- 100 125 75 -- 
Streptococcus facecalis 175 125 200 200 100 125 100 125 
Figure 3: Minimum Inhibitory effect of pathogenic bacteria in the agar-diffusion method for ligands 
and Complexes in mm at 100µg/ml: 
 
 
Results of Table 1 and 2 evidenced that complexes were showed better antimicrobial potentials than the ligands. Average 
zone of inhibitions obtained using complexes were much higher when compared to ligands. C2 complex yielded zone of 
inhibition ranges from 10mm to 20mm whereas L2 ligand yielded 0 – 13mm zone of inhibition. Average zone of inhibition of 
complexes were C1-12.1mm; C3-15.7mm; C4-12.7mm & C2-14mm. Ligands produced variable and lower zone of inhibition, 
which were L1- 9.5mm; L3-10.8mm; L4-9.5mm and L2-10mm. The establishments of the minimum inhibitory concentrations 
(MICs) of antimicrobial means are a more precise method for determination of their effect. MIC effect of both ligands and 
complexes were performed by adopting standard protocol called Drug dilution method. Ligands inhibited the growth of gram 
positive and gram- negative pathogenic bacteria and concentration required to inhibits the growth ranges from 100µ g/ml 
concentrations to more than 1000 µ g/ml concentrations (Table 2). Complexes also prevent the growth of bacteria, its 
concentration ranges from 25 to 250 µ g/ml concentrations (Table 2). Here also complexes showed better activity when 
compared to ligands. C3 inhibited pathogenic bacteria like E. coli, Aeromonas sp., and Enterobacter at 25 µ g/ml 
concentrations whereas the same bacteria were inhibited by the ligands at higher concentrations (E. coli - 100 δ g/ml, 
Aeromonas sp., - 100 µ g/ml and Enterobacter at 75 µ g/ml concentrations). Mononuclear complexes and ligands showed 
slightly better antimicrobial activity against all the pathogens tested. 
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Among the compounds tested Fe2  (TBSHMD) (C2) was found to be most active with the lowest MIC against the gram positive 
bacteria .The highest MICs were established for Fe (NHAD) Cl2  (C3). The sensitivity of Gam – positive bacteria to Fe(NHAD)Cl2 
were slightly higher as compared  to Fe(NHTEN)Cl2  (C4)and lower than those to Fe 2(TBSHMD)Cl2  but the difference were not 
signif icant. For most Gram-positive bacteria tested the MIC’s established by four iron complexes were mostly similar.   For, 
Lactobacillus sp, and Pseudomonas aeruginosa. The MICs were lower for Fe2  (TBSHMD) Cl2   than those of other two iron 
complexes. On the other hand Fe (NHAD) Cl2  showed highest activity against E. coli and E. aerogens. The control solution PBS 
containing the same concentration of DMSO as samples examined when tested independently by both methods. The results 
obtained showed that the bacterial strains used in the experiments were sensitive to iron complexes investigated in spite of that 
their ligands. 
 
Conclusions 
According to Okama et al (1990)²² the antimicrobial activity of the drugs increased in a low iron environment and decreased in 
the presence of a high iron concentration (occurrence for the site penetration-receptors). Many pathogenic bacteria receive their 
essential iron by assimilation through cell surface receptors (Diarra et al., 1996). Probably the bacteria assimilate better iron 
compounds than the copper ones due to use of haeme uptake mechanism.The antimicrobial activity of iron complexes with 
ligands containing  catechol  moiety N,N  bis(naphthy 2-hydroxy) 1,3 diamminopropane  (NHDAP);(C-3) N,N bis (naphthy 2- 
hydroxy) triethylenetetrammine (NHTEN);(C-4) N,N bis (t-Butylsalicyl 2hydroxy) 4,4”diamminodiphenylmethane (TBSHMD); (C- 
2) N,N bis (t-Butylsalicyl-2-hydroxy) 4,4”oxydianiline -(TBSHOD)(C-1). The examined mononuclear iron complex has more or 
less pronounced effect in Gram positive and Gram negative strains as compared to that of dinuclear complex. The imperfect 
solubility of the dinuclear iron complexes could be considered as one of the  constrain for obtaining much better antibacterial 
activity when compared to mononuclear complexes.The examined mononuclear iron complexes has more or lesspronounced 
effect in gram positive and gram negative strains ascompared to that of dinuclear complex. The examined ironcomplexes 
manifest inhibitory activity against gram positive andgram negative bacterial strains in the experiments. The complexesof Fe 
(III) with (NHAD) &, (NHTEN), Diiron with (TBSHMD) are moreactive than that of  dinuclear complexes (TBSHOD).The 
dinuclearcomplexes of (TBSHOD) has less active compared to others becauseof the presence of oxydianiline which hinder the 
activity. The schiffsbases, which were inactive before complex become active and less active one. 
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